Arbutus Biopharma (I9DN) Q2 2026 Earnings Report
DE:I9DN Q2 2026 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- EUR 0.01
DE:I9DN Q2 2026 Revenue Results
- Actual Revenue
- EUR 907.93K
- Expected Revenue
- EUR 626.78K
- Beat/Miss
- Beat by +EUR 281.15K
- YoY Revenue Growth
- -90.56%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 12, 2026
DE:I9DN Upcoming Earnings
Arbutus Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:I9DN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.02- | -0.04 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | -0.02-0.03 | 0.01 | -400.00% (-0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.030.78 | -0.12 | 769.23% (+0.90) | |
| Mar 23, 2026 | 2025 (Q4) | -0.03-0.01 | -0.06 | 85.71% (+0.05) | |
| Nov 13, 2025 | 2025 (Q3) | -0.03-0.04 | -0.09 | 60.00% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.040.01 | -0.1 | 109.09% (+0.11) | |
| May 14, 2025 | 2025 (Q1) | -0.09-0.12 | -0.09 | -30.00% (-0.03) | |
| Mar 27, 2025 | 2024 (Q4) | -0.07-0.06 | -0.11 | 41.67% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | -0.08-0.09 | -0.11 | 16.67% (+0.02) | |
| Aug 01, 2024 | 2024 (Q2) | -0.09-0.10 | -0.09 | -10.00% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
